Evidence map›Paper›PMID 31878261›Full record

ArticleMolecules (Basel, Switzerland)2019

(-)-

Motohiko Ukiya, Daisuke Sato, Hirokazu Kimura, Mamoru Koketsu, Nyunt Phay, Atsuyoshi Nishina

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 2 countries.

Motohiko UkiyaCollege of Science and Technology, Nihon University, 1-5-1 Kandasurugadai, Chiyoda, Tokyo 101-0062, Japan.
Daisuke SatoDepartment of Biomedical Information Engineering, Graduate School of Medical Science, Yamagata University, 2-2-2 Iidanishi, Yamagata 990-9585, Japan.
Hirokazu KimuraSchool of Medical Technology, Faculty of Health Science, Gunma Paz University, 1-7-1 Tonyamachi, Takasaki, Gunma 370-0006, Japan.
Mamoru KoketsuDepartment of Chemistry and Biomolecular Science, Faculty of Engineering, Gifu University, 1-1 Yanagido, Gifu 501-1193, Japan.ORCID 0000-0002-1496-2177
Nyunt PhayBotany Department, Pathein University, Main Rd, Pathein 10014, Myanmar.
Atsuyoshi NishinaCollege of Science and Technology, Nihon University, 1-5-1 Kandasurugadai, Chiyoda, Tokyo 101-0062, Japan.
Nihon University · JPGifu University · JPGumma Paz College · JPTechnological University Pathein · MMYamagata University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, for the purpose of elucidation for antidiabetic components, we isolated and identified compounds that could become lead compounds for the development of antidiabetic agents from the herbal medicine

Indexed as

3T3-L1 CellsAdipogenesisAdiponectinAnimalsBerberineCell DeathCell MembraneGlucose Transporter Type 4LignansLipid MetabolismMAP Kinase Signaling SystemMicep38 Mitogen-Activated Protein KinasesPhosphorylationPlant ExtractsPPAR gammaAdiponectinBerberinecubebinGlucose Transporter Type 4Lignansp38 Mitogen-Activated Protein KinasesPlant ExtractsPPAR gammaProtein Kinase InhibitorsRosiglitazoneadipogenesislipogenesislipolysis(-)-O-methylcubebinrosiglitazoneVitex trifolia L.

Identifiers

PMID31878261
PMCPMC6994966
OpenAlexW2997855401

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.